Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5390320 | 1.00 | CYP2B6 (0.32) | CYP2B6MGLL | |
| Ammonia Solution, Strong SCHEMBL31168140 | 0.97 | CYP2B6 (0.31) | CYP2B6 | |
| Hydrochloric Acid SCHEMBL9035395 | 0.97 | CYP2B6 (0.31) | CYP2B6 | |
| Hydrochloric Acid SCHEMBL1507301 | 0.97 | CYP2B6 (0.31) | CYP2B6 | |
| Bromide SCHEMBL29204968 | 0.97 | CYP2B6 (0.31) | CYP2B6 | |
| SCHEMBL7048888 | 0.96 | — | — | |
| SCHEMBL518019 | 0.96 | — | — | |
| Hydrochloric Acid SCHEMBL16238627 | 0.93 | — | — | |
| SCHEMBL3505975 | 0.89 | — | — | |
| SCHEMBL10006193 | 0.86 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 354 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12502386-B2 | Nitrogen-containing heterocyclic compound and use thereof | Shanghai Shijiang Biotechnology Co., Ltd. (CN) | 2025-12-23 | — | — | US | claimed |
| US-20250197389-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND | SHANGHAI SHIJIANG BIOTECHNOLOGY CO., LTD (CN) | 2025-06-19 | — | — | US | claimed |
| US-20250197415-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND USE THEREOF | SHANGHAI SHIJIANG BIOTECHNOLOGY CO., LTD (CN) | 2025-06-19 | — | — | US | claimed |
| CN-114430064-B | In-situ preparation and application of polymer solid electrolyte | 深圳先进技术研究院 | 2024-09-20 | — | — | CN | claimed |
| CN-118580470-A | Cationic polymer based on halogenated m-terphenyl group, and preparation method and application thereof | 西湖大学 | 2024-09-03 | — | — | CN | claimed |
| CN-117728010-A | Solid electrolyte material, preparation method and solid battery | 蜂巢能源科技(无锡)有限公司 | 2024-03-19 | — | — | CN | claimed |
| US-11787785-B2 | Pyrazolopyridine derivatives and uses thereof | NOVARTIS AG (CH) | 2023-10-17 | — | — | US | claimed |
| US-20230108325-A1 | Pyrazolopyridine Derivatives and Uses thereof | NOVARTIS AG (CH) | 2023-04-06 | — | — | US | claimed |
| US-10221172-B2 | Benzothiazole and benzisothiazole-substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction | VANDERBILT UNIVERSITY (US) | 2019-03-05 | — | — | US | claimed |
| US-20180022744-A1 | BENZOTHIAZOLE AND BENZISOTHIAZOLE-SUBSTITUTED COMPOUNDS AS MGLUR4 ALLOSTERIC POTENTIATORS, COMPOSITIONS, AND METHODS OF TREATING NEUROLOGICAL DYSFUNCTION | VANDERBILT UNIVERSITY | 2018-01-25 | — | — | US | claimed |
| WO-1997042155-A1 | ANTI-VIRAL COMPOUNDS | ELI LILLY AND COMPANY (US) | 1997-11-13 | — | — | WO | claimed |
| WO-1997041849-A1 | ANTI-VIRAL METHOD | ELI LILLY AND COMPANY (US) | 1997-11-13 | — | — | WO | claimed |
| WO-1997042156-A1 | ANTI-VIRAL COMPOUNDS | ELI LILLY AND COMPANY (US) | 1997-11-13 | — | — | WO | claimed |
| WO-1997041822-A2 | ANTI-VIRAL COMPOUNDS | ELI LILLY AND COMPANY (US) | 1997-11-13 | — | — | WO | claimed |
| EP-0806203-A2 | Anti-viral compositions | ELI LILLY AND COMPANY (US) | 1997-11-12 | — | — | EP | claimed |
| EP-0806411-A2 | Anti-viral compounds | ELI LILLY AND COMPANY (US) | 1997-11-12 | — | — | EP | claimed |
| EP-0806409-A1 | Anti-viral compounds | ELI LILLY AND COMPANY (US) | 1997-11-12 | — | — | EP | claimed |
| EP-0806410-A2 | Anti-viral compounds | ELI LILLY AND COMPANY (US) | 1997-11-12 | — | — | EP | claimed |
| EP-0806408-A1 | Anti-viral compounds | ELI LILLY AND COMPANY (US) | 1997-11-12 | — | — | EP | claimed |
| EP-0764641-A1 | NOVEL 4,5-DISUBSTITUTED PYRIMIDINE DERIVATIVE AND HERBICIDE | NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) | 1997-03-26 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11787785-B2 | Pyrazolopyridine derivatives and uses thereof | HBZ, ZFX, WIZ | CYP2B6 2986/4885MGLL 4859/4885 |
| US-20250197389-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND | PPIF, PIN1, NME4 | CYP2B6 1755/4885MGLL 4575/4885 |
| US-20180022744-A1 | BENZOTHIAZOLE AND BENZISOTHIAZOLE-SUBSTITUTED COMPOUNDS AS MGLUR4 ALLOSTERIC POTENTIATORS, COMPOSITIONS, AND METHODS OF TREATING NEUROLOGICAL DYSFUNCTION | GRM4, GRIK4, GRIA4 | CYP2B6 3223/4885MGLL 3293/4885 |
| US-10221172-B2 | Benzothiazole and benzisothiazole-substituted compounds as mGluR4 allosteric potentiators, compositions, and methods of treating neurological dysfunction | GRM4, GRIK4, GRIA4 | CYP2B6 3223/4885MGLL 3293/4885 |
| US-20230108325-A1 | Pyrazolopyridine Derivatives and Uses thereof | HBZ, ZFX, WIZ | CYP2B6 2986/4885MGLL 4859/4885 |
| US-20250197415-A1 | NITROGEN-CONTAINING HETEROCYCLIC COMPOUND AND USE THEREOF | UHRF1, NNMT, EHMT1 | CYP2B6 2003/4885MGLL 4862/4885 |
| US-12502386-B2 | Nitrogen-containing heterocyclic compound and use thereof | UHRF1, NNMT, EHMT1 | CYP2B6 2003/4885MGLL 4862/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.